Diabetic Foot Ulcers Clinical Trial
Official title:
Passive Training as a Treatment for Diabetic Foot Ulcers: A Randomized, Single-blinded Clinical Trial of Wound Healing
Overall project design: This PhD project involves a randomized study on diabetic individuals
with healing resistant wounds, comparing the effect of passive movement of the lower limb
with standard treatment of diabetic wounds.
How to effectively improve the condition of peripheral arterial disease is limited. The
primary purpose of this study is to uncover whether passive movement of the lower limb will
influence muscle oxygen demand and thereby increasing blood flow. An increase in muscle
oxygen demand is likely to increase both blood flow rate and the number of capillaries, which
would induce the healing of wounds, that were not previously possible.
The secondary purpose is to increase understanding of the pathophysiological processes in
wound healing through the study of biochemical markers of vascularization, inflammation and
stem cell recruitment in blood samples. Further on analyzing the skin and muscle biopsies of
the number and quality of endothelial cells and Capillary density and to develop new
quantifiable methods to evaluate wound healing in.
The project is a randomized trial, consisting of simple passive training to improve blood
vessel function, increase the growth of the smallest blood vessels, thereby preventing
ulceration and ultimately amputation.
Background information
Diabetic foot ulcers are one of the most frequent and serious complication in diabetes
mellitus. Despite attempts of prophylaxis*, only two-thirds of the diabetic foot ulcers
eventually heal, and up to 15-20% will ultimately require a minor or major amputation (Major
lower extremity amputation is defined as through or above the ankle joint, and minor
amputations is below the ankle joint. The incidence of diabetes is growing, but the
multifactorial causes of impaired healing of chronic diabetic ulcers are still not well
understood.
The diabetic foot ulcers are known to reduce the quality of life for patients both
psychically and psychologically and therefore further investigation in new treatment options
is plausible. Current knowledge regarding how to improve the condition in the beginning phase
of peripheral artery disease (PAD) is limited. Investigators know that high oxygen tension
and perfusion of the limb as well as an adequate density of microvessels in the tissue, is
essential to wound healing. Therefore, interventions that increase blood flow and promote
microcirculatory growth are likely to be beneficial in the treatment of wound healing.
*Dressings, debridement, compression, clinical observation, antibiotics and glycemic control
It has been reported that passive training consisting of knee flexion/extension in a kinetic
machine has a beneficial effect on up regulation of growth factors, remicrovascularization
and improved blood flow. Høier et al described that passive movement of the leg induced a
two-fold elevation in blood flow, elevation of angiogenic factors and initiates
capillarization in skeletal muscle. All three factors are often impaired in the diabetic leg,
which results in poor wound healing.
Due to the typical localization of the diabetic foot ulcers, this patient group is unable to
exercise properly. Therefore will the investigators use a recent innovative model for the
improvement of the limb microcirculation, developed at the Department of Nutrition, Exercise
and Sports, University of Copenhagen, involving passive movement of the lower leg, for
inducing increased blood flow and microcirculatory growth.
Rationale for the trial Diabetic patients have impaired wound healing due to multifactorial
causes. The investigators know that high oxygen tension, and perfusion is essential to wound
healing, and according to Høier et al's study, passive training can increase the perfusion
and elevate proangiogenic factors in both young healthy males and peripheral artery disease
(PAD) patients.
Null hypothesis:
1. Passive training does not lead to enhanced healing of diabetic foot ulcers.
2. Passive training of the lower limb does not affect perfusion of the trained limb.
Perspective:
This projects aim is to discover that passive training of the lower limb will increase the
healing in diabetic foot ulcers. In addition, present a new treatment offer to diabetic
patients with ulcers, who are not able to heal properly or perform active exercises. The
investigators hope to see that the benefits of training and accelerated healing affect the
PROM's.
Further on to present new knowledge of the specific molecular and functional changes that
occur in the tissue during wound healing. This knowledge will be very important to improve
our understanding of why ulcerations occur and why the tissue begins to decompose.
This is a prospective, randomized, single-blinded, parallel controlled design trial in
subjects with diabetes mellitus investigating passive training as a treatment for the
diabetic ulcer. The participants are randomized to either a control group or intervention.
The control group receiving standard wound treatment, and an intervention group receiving
standard wound treatment, and passive training exercises for 8 weeks. The participants will
be followed for 16 weeks or until clinical wound healing. All participants will receive
standard wound care consisting of debridement, dressings, compression, offloading footwear
and if necessary antibiotics The comparison groups should be as similar as possible as regard
to important participant characteristics that might influence the response to the
intervention. Therefore, a block randomization to ensure that equal numbers of participants
with a characteristic thought to affect prognosis or response to the intervention, will be
allocated to each comparison group.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02652754 -
Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Diabetic Foot Ulcers
|
Phase 1 | |
Completed |
NCT01070433 -
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers
|
Phase 2 | |
Completed |
NCT00971048 -
Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness Wounds
|
N/A | |
Terminated |
NCT00762138 -
The AutoloGel™ Post-Market Surveillance (TAPS) Program
|
N/A | |
Completed |
NCT00578604 -
Non-Invasive Assessment of Wound Healing With Optical Methods
|
N/A | |
Completed |
NCT05417425 -
Omeza Products in Combination With Standard of Care for the Treatment of Diabetic Foot Ulcers
|
Phase 1 | |
Completed |
NCT02631512 -
Evaluation of Woulgan in Diabetic Foot Ulcer
|
Phase 4 | |
Terminated |
NCT01816633 -
Effectiveness of AutoloGel Therapy in Diabetic Foot Ulcers
|
N/A | |
Completed |
NCT02222376 -
Effect of Topic Pirfenidone in Diabetic Ulcers
|
Phase 3 | |
Completed |
NCT01221207 -
Instant Total Contact Cast to Heal Diabetic Foot Ulcers
|
N/A | |
Completed |
NCT01454401 -
LeucoPatch™ Study A Multicenter Study on the Effect of LeucoPatch™ in Diabetic Foot Ulcers
|
N/A | |
Withdrawn |
NCT01105884 -
Clinical and Cost Effectiveness of Different Dressing Materials in Diabetic Foot Ulcers
|
N/A | |
Completed |
NCT01291160 -
Transdermal Continuous Oxygen Therapy for Diabetic Foot Ulcers
|
Phase 2/Phase 3 | |
Completed |
NCT00536744 -
Effectiveness of dermaPACE™ Device and Standard Treatment Compared to Standard Treatment Alone for Diabetic Foot Ulcers
|
Phase 3 | |
Terminated |
NCT00316537 -
Safety and Preliminary Efficacy Study of Nicotine Gel to Treat Diabetic Foot Ulcers
|
Phase 1/Phase 2 | |
Completed |
NCT00013299 -
Clinical Trials of Footwear in Patients With Diabetes-Study Arm 2,3
|
Phase 2 | |
Completed |
NCT00013286 -
A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk
|
Phase 2 | |
Terminated |
NCT02667327 -
A Study of Granexin Gel in the Treatment of Diabetic Foot Ulcer
|
Phase 3 | |
Not yet recruiting |
NCT00916292 -
Safety Study of Topical Human FGF-1 for Wound Healing
|
Phase 1 | |
Completed |
NCT01154374 -
A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot)
|
Phase 2 |